CoChat
Sign Up
Cited by 168

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review

Indoria, Shikha, Singh, Vickramjeet, Hsieh, Ming-Fa·2020·International Journal of Pharmaceutics
DOI 10.1016/j.ijpharm.2020.119314
Open this paper in CoChat — free account

Abstract

Nanotheranostics is fast-growing pharmaceutical technology for simultaneously monitoring drug release and its distribution, and to evaluate the real time therapeutic efficacy through a single nanoscale for treatment and diagnosis of deadly disease such as cancers. In recent two decades, biodegradable polymers have been discovered as important carriers to accommodate therapeutic and medical imaging agents to facilitate construction of multi-modal formulations. In this review, we summarize various multifunctional polymeric nano-sized formulations such as polymer-based super paramagnetic nanoparticles, ultrasound-triggered polymeric nanoparticles, polymeric nanoparticles bearing radionuclides, and fluorescent polymeric nano-sized formulations for purpose of theranostics. The use of such multi-modal nano-sized formulations for near future clinical trials can assist clinicians to predict therapeutic properties (for instance, depending upon the quantity of drug accumulated at the cancerous site) and observed the progress of tumor growth in patients, thus improving tailored medicines.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2020.119314

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 10 references

Research works printed but not linked: 172

  1. Ahmed, 2012, Theranostic applications of nanoparticles in cancer, Drug Discov. Today, 17, 929, 10.1016/j.drudis.2012.03.010 · DOI
  2. Ali, 2020, Progress in polymeric nano-medicines for theranostic cancer treatment, Polymers, 12, 598, 10.3390/polym12030598 · DOI
  3. Alsehli, 2020, Polymeric nanocarriers as stimuli-responsive systems for targeted tumor(cancer) therapy: Recent advances in drug delivery, Saudi Pharm. J., 28, 255, 10.1016/j.jsps.2020.01.004 · DOI
  4. Andreiuk, 2017, Fluorescent polymer nanoparticles for cell barcoding in vitro and in vivo, Small, 13, 1701582, 10.1002/smll.201701582 · DOI · Paper page
  5. Andreou, 2017, “Molecular Imaging in Nanotechnology and Theranostics” (MINT) interest group, Mol. Imag. Biol., 19, 363, 10.1007/s11307-017-1056-z · DOI
  6. Arranja, 2017, Tumor-targeted nanomedicines for cancer theranostics, Pharmacol. Res., 115, 87, 10.1016/j.phrs.2016.11.014 · DOI
  7. Arruebo, 2007, Nano Today, 2, 22, 10.1016/S1748-0132(07)70084-1 · DOI
  8. AshaRani, 2009, Cytotoxicity and genotoxicity of silver nanoparticles in human cells, ACS Nano, 3, 279, 10.1021/nn800596w · DOI
  9. Bae, 2011, Nanomaterials for cancer therapy and imaging, Mol. Cells, 31, 295, 10.1007/s10059-011-0051-5 · DOI
  10. Bagalkot, 2007, Quantum Dot-Aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer, Nano Lett., 7, 3065, 10.1021/nl071546n · DOI
  11. Baskar, 2012, Cancer and radiation therapy: current advances and future directions, Int. J. Med. Sci., 9, 193, 10.7150/ijms.3635 · DOI
  12. Baum, 2012, THERANOSTICS: from molecular imaging using 68Ga labeled tracers and PET/CT to Personalized radionuclide therapy - the bad berka experience, Theranostics, 2, 437, 10.7150/thno.3645 · DOI
  13. Bogdanov, 2011, Molecular MR contrast agents for the detection of cancer: past and present, Semin. Oncol., 38, 42, 10.1053/j.seminoncol.2010.11.002 · DOI
  14. Boros, 2019, Radioactive transition metals for imaging and therapy, Chem. Rev., 119, 870, 10.1021/acs.chemrev.8b00281 · DOI
  15. Braeken, 2017, Conjugated polymer nanoparticles for bioimaging, Materials, 10, 1420, 10.3390/ma10121420 · DOI
  16. Cai, 2017, Preparation of polyacrylic acid surface-crosslinked strong fluorescent polymer nanoparticles and their sensitive in vitro imaging of cancer cells and longlife in vivo imaging of in situ tumors, Anal. Methods, 9, 4797, 10.1039/C7AY01392B · DOI
  17. Canavesea, 2018, Nanoparticle-assisted ultrasound: a special focus on sonodynamic therapy against cancer, Chem. Eng. J., 340, 155, 10.1016/j.cej.2018.01.060 · DOI
  18. Cavalieri, 2008, Polymer microbubbles as diagnostic and therapeutic gas delivery device, Chem. Mater., 20, 3254, 10.1021/cm703702d · DOI
  19. Cerqueira, 2015, Receptor-based virtual screening protocol for drug discovery, Arch. Biochem. Biophys., 582, 56, 10.1016/j.abb.2015.05.011 · DOI
  20. Chan, 2011, In vivo Prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles, Proc. Nat. Acad. Sci. USA, 108, 19347, 10.1073/pnas.1115945108 · DOI
  21. Chen, 2014, Fragmented polymer nanotubes from sonication induced scission with a thermo-responsive gating system for anti-cancer drug delivery, J. Mater. Chem. B, 2, 1327, 10.1039/C3TB21512A · DOI
  22. Chen, 2013, Ultrasound and pH dually responsive polymer vesicles for anticancer drug delivery, Sci. Rep., 3, 2162, 10.1038/srep02162 · DOI
  23. Cho, 2007, In Vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications, Biomaterials, 28, 1236, 10.1016/j.biomaterials.2006.10.002 · DOI
  24. Choi, 2012, Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives, Nanoscale, 4, 330, 10.1039/C1NR11277E · DOI
  25. Choi, 2009, Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells, J. Inorg. Biochem., 03, 463, 10.1016/j.jinorgbio.2008.12.017 · DOI
  26. Chowdhury, 2017, Ultrasound-guided drug delivery in cancer, Ultrasonography, 36, 171, 10.14366/usg.17021 · DOI
  27. Cova, 2019, Computational approaches in theranostics: mining and predicting cancer data, Pharmaceutics, 11, 119, 10.3390/pharmaceutics11030119 · DOI · Paper page
  28. Cubeddu, 2002, Time-resolved fluorescence imaging in biology and medicine, J. Phys. D Appl. Phys., 35, R61, 10.1088/0022-3727/35/9/201 · DOI
  29. Cuong, 2011, Doxorubicin-loaded PEG-PCL-PEG micelle using xenograft model of nude mice: effect of multiple administration of micelle on the suppression of human breast cancer, Cancers, 3, 61, 10.3390/cancers3010061 · DOI
  30. Cuong, 2009, Recent advances in pharmacokinetics of polymeric excipients used in nanosized anti-cancer drugs, Curr. Drug Metab., 10, 842, 10.2174/138920009790274586 · DOI
  31. Cuong, 2010, Synthesis and characterization of PEG-PCL-PEG triblock copolymers as carriers of doxorubicin for the treatment of breast cancer, J. Appl. Polym. Sci., 117, 3694, 10.1002/app.32266 · DOI
  32. Cuong, 2010, Doxorubicin-loaded nanosized micelles of a starshaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer, J. Biomater. Sci. Polym. Ed., 22, 1409, 10.1163/092050610X510533 · DOI
  33. d’Esposito, 2018, Computational fluid dynamics with imaging of cleared tissue and of in vivo perfusion predicts drug uptake and treatment responses in tumours, Nat. Biomed. Eng., 2, 773, 10.1038/s41551-018-0306-y · DOI
  34. Deckers, 2008, The role of ultrasound and magnetic resonance in local drug delivery, J. Magn. Reson. Imaging, 27, 400, 10.1002/jmri.21272 · DOI
  35. Deckers, 2010, Ultrasound triggered, image guided, local drug delivery, J. Control. Release, 148, 25, 10.1016/j.jconrel.2010.07.117 · DOI
  36. Dolmans, 2003, Photodynamic therapy for cancer, Nat. Rev. Cancer, 3, 380, 10.1038/nrc1071 · DOI
  37. Domenici, 2013, Ultrasound well below the intensity threshold of cavitation can promote efficient uptake of small drug model molecules in fibroblast cells, Drug Delivery, 20, 285, 10.3109/10717544.2013.836620 · DOI
  38. Dreifuss, 2015, A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?, Nanoscale, 7, 15175, 10.1039/C5NR03119B · DOI
  39. Drude, 2017, Theranostic and nanotheranostic probes in nuclear medicine, Methods, 130, 14, 10.1016/j.ymeth.2017.07.004 · DOI
  40. Duncan, 2003, The dawning Era of polymer therapeutics, Nat. Rev., 2, 347
  41. Fahey, 2017, Saul Hertz, MD, and the birth of radionuclide therapy, EJNMMI Phys., 4, 15, 10.1186/s40658-017-0182-7 · DOI
  42. Fan, 2014, Theranostic nanomedicine for cancer detection and treatment, J. Food Drug Anal., 22, 3, 10.1016/j.jfda.2014.01.001 · DOI
  43. Feng, 2017, Multifunctional conjugated polymer nanoparticles for image-guided photodynamic and photothermal therapy, Small, 13, 1602807, 10.1002/smll.201602807 · DOI
  44. Fernández-Suárez, 2008, Fluorescent probes for super-resolution imaging in living cells, Nat. Rev. Mol. Cell Biol., 9, 929, 10.1038/nrm2531 · DOI
  45. Ferrara, 2008, Driving delivery vehicles with ultrasound, Adv. Drug Deliv. Rev., 60, 1097, 10.1016/j.addr.2008.03.002 · DOI
  46. Frangioni, 2003, In vivo near-infrared fluorescence imaging, Curr. Opinion Chem. Biol., 7, 626, 10.1016/j.cbpa.2003.08.007 · DOI
  47. Frenkel, 2008, Ultrasound mediated delivery of drugs and genes to solid tumors, Adv. Drug Deliv. Rev., 60, 1193, 10.1016/j.addr.2008.03.007 · DOI
  48. Freudenberg, 2018, Molecular imaging using the theranostic agent 197 (m) Hg: phantom measurements and Monte Carlo simulations, EJNMMI Phys., 5, 15, 10.1186/s40658-018-0216-9 · DOI
  49. Funkhouser, 2002, Reinventing pharma: the theranostic revolution, Curr. Drug Discov., 2, 17
  50. Galanzha, 2009, Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in-vivo detection and killing of circulating cancer stem cells, J. Biophoton., 2, 725, 10.1002/jbio.200910078 · DOI
  51. Galanzha, 2009, In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser, Cancer Res., 69, 7926, 10.1158/0008-5472.CAN-08-4900 · DOI
  52. Gan, 2018, Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics, Int. J. Nanomed., 13, 4263, 10.2147/IJN.S164817 · DOI
  53. Gao, 2005, Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound, J. Control. Rel., 102, 203, 10.1016/j.jconrel.2004.09.021 · DOI
  54. Gao, 2008, Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy, Ultrasonics, 48, 260, 10.1016/j.ultras.2007.11.002 · DOI
  55. Ghanem, 1993, Labelled polycyanoacrylate nanoparticles for human in vivo use, Appl. Radiat. Isot., 44, 1219, 10.1016/0969-8043(93)90068-L · DOI
  56. Gobbo, 2015, Magnetic nanoparticles in cancer theranostics, Theranostics, 5, 1249, 10.7150/thno.11544 · DOI
  57. Gourevich, 2013, Ultrasound-mediated targeted drug delivery with a novel cyclodextrin-based drug carrier by mechanical and thermal mechanisms, J. Control. Rel., 170, 316, 10.1016/j.jconrel.2013.05.038 · DOI
  58. Gratton, 2008, The effect of particle design on cellular internalization pathways, Proc. Natl. Acad. Sci., 105, 11613, 10.1073/pnas.0801763105 · DOI · Paper page
  59. Gu, 2010, Hybrid nanocomposites of semiconductor nanoparticles and conjugated polyelectrolytes and their application as fluorescence biosensors, Polymer, 51, 902, 10.1016/j.polymer.2009.12.035 · DOI
  60. Guan, 2012, The apoptosis of OVCAR-3 induced by TNF-a plus IFN-g co-immobilized polylactic acid copolymers, J. Mater. Chem., 22, 14746, 10.1039/c2jm31972a · DOI
  61. Guthi, 2009, MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells, Mol. Pharm., 7, 32, 10.1021/mp9001393 · DOI
  62. Haar, 2011, Ultrasonic imaging: safety considerations. Interface, Focus, 1, 686
  63. Hajba, 2016, The use of magnetic nanoparticles in cancer theranostics: toward handheld diagnostic devices, Biotechnol. Adv., 34, 354, 10.1016/j.biotechadv.2016.02.001 · DOI · Paper page
  64. Hameed, 2018, Cerasomes and BICELLES: hybrid bilayered nanostructures with silica-like surface in cancer theranostics, Front. Chem., 6, 1
  65. Hong, 2013, pH-responsive theranostic polymer-caged nanobins: enhanced cytotoxicity and T-1 MRI contrast by Her2 targeting, Part. Part. Syst. Char., 30, 770, 10.1002/ppsc.201300158 · DOI
  66. Hou, 2011, Synthesis of novel folate conjugated fluorescent nanoparticles for tumor imaging, J. Biomed. Mater. Res. Part A, 99, 684, 10.1002/jbm.a.33187 · DOI
  67. Hsieh, 2005, Biodegradable polymeric nanoparticles bearing stealth peg shell and lipophilic polyester core, J. Chin. Inst. Chem. Eng., 36, 609
  68. Huang, 2006, Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods, J. Am. Chem. Soc., 128, 2115, 10.1021/ja057254a · DOI
  69. Huang, 2017, Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics, Mater. Sci. Eng., C, 70, 763, 10.1016/j.msec.2016.09.052 · DOI
  70. Husseini, 2009, Ultrasonic-activated micellar drug delivery for cancer treatment, J. Pharm. Sci., 98, 795, 10.1002/jps.21444 · DOI · Paper page
  71. Jiang, 2017, Amphiphilic semiconducting polymer as multifunctional nanocarrier for fluorescence/photoacoustic imaging guided chemo-photothermal therapy, Biomaterials, 145, 168, 10.1016/j.biomaterials.2017.08.037 · DOI
  72. Johnson, R.P., Preman, N.K., 2019. Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications. Volume 2: Advanced Nanocarriers for Therapeutics. Woodhead Publishing Series in Biomaterials, Elsevier, pp. 249–267. · DOI
  73. Jung, 2012, Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer, Int. J. Radiat. Oncol. Biol. Phys., 84, 77, 10.1016/j.ijrobp.2012.02.030 · DOI
  74. Kang, 2018, pH-responsible fluorescent carbon nanoparticles for tumor selective theranostics via ph-turn on/off fluorescence and photothermal effect in vivo and in vitro, Nanoscale, 10, 2512, 10.1039/C7NR07900A · DOI
  75. Kim, 2009, Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents, Nat. Nanotechnol., 4, 688, 10.1038/nnano.2009.231 · DOI
  76. Kim, 2010, Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring, J. Control. Rel., 146, 219, 10.1016/j.jconrel.2010.04.004 · DOI
  77. Krasia-Christoforou, 2013, Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy, J. Mater. Chem. B, 1, 3002, 10.1039/c3tb20191k · DOI
  78. Kumar, 2012, In Vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer, Theranostics, 2, 714, 10.7150/thno.3927 · DOI
  79. Lammers, 2008, Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy, Br. J. Cancer, 99, 900, 10.1038/sj.bjc.6604561 · DOI
  80. Langbein, 2019, Future of theranostics: an outlook on precision oncology in nuclear medicine, J. Nucl. Med., 60, 13S, 10.2967/jnumed.118.220566 · DOI
  81. Lee, 2010, Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release, Angew. Chem. Int. Ed., 49, 9960, 10.1002/anie.201004867 · DOI
  82. Li, 2014, pH-responsive biocompatible fluorescent polymer nanoparticles based on phenylboronic acid for intracellular imaging and drug delivery, Nanoscale, 6, 13701, 10.1039/C4NR04054F · DOI
  83. Li, 2011, Amphiphilic multiarm star block copolymer-based multifunctional unimolecular micelles for cancer targeted drug delivery and MR imaging, Biomaterials, 32, 6595, 10.1016/j.biomaterials.2011.05.049 · DOI
  84. Li, 2014, Conjugated-polymer-based red-emitting nanoparticles for two- photon excitation cell imaging with high contrast, Langmuir, 30, 7623, 10.1021/la501790y · DOI
  85. Liao, 2011, Multifunctional nanoparticles composed of a poly(DL-lactide-co-glycolide) core and a paramagnetic liposome shell for simultaneous magnetic resonance imaging and targeted, Adv. Funct. Mater., 21, 1179, 10.1002/adfm.201002314 · DOI
  86. Lim, 2015, Nanomaterials for theranostics: recent advances and future challenges, Chem. Rev., 115, 327, 10.1021/cr300213b · DOI
  87. Lin, 2018, Multifunctional PEGylated Albumin/IR780/Iron oxide nanocomplexes for cancer photothermal therapy and MR imaging, Nanotheranostics, 2, 106, 10.7150/ntno.19379 · DOI
  88. Ling, 2011, Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy, Biomaterials, 32, 7139, 10.1016/j.biomaterials.2011.05.089 · DOI
  89. Lison, 2008, Lung and systemic responses to carbon nanotubes (CNT) in mice, Toxicol. Sci., 101, 179, 10.1093/toxsci/kfm249 · DOI
  90. Liu, 2019, Artificial intelligence and big data facilitated targeted drug discovery, Stroke Vascular Neurol., 4, e000290, 10.1136/svn-2019-000290 · DOI
  91. Liu, 2015, Chemotherapy targeting cancer stem cells, Am. J. Cancer Res., 5, 880
  92. Liu, 2012, cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer, Biomaterials, 33, 6739, 10.1016/j.biomaterials.2012.06.008 · DOI
  93. Liu, 2012, Gadolinium loaded nanoparticles in theranostic magnetic resonance imaging, Biomaterials, 33, 5363, 10.1016/j.biomaterials.2012.03.084 · DOI
  94. Lovell, 2010, Activatable photosensitizers for imaging and therapy, Chem. Rev., 110, 2839, 10.1021/cr900236h · DOI
  95. Luk, 2014, Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis, ACS Appl. Mater. Interfaces, 6, 21859, 10.1021/am5036225 · DOI
  96. Luo, 2011, A review of NIR dyes in cancer targeting and imaging, Biomaterials, 32, 7127, 10.1016/j.biomaterials.2011.06.024 · DOI
  97. Lux, 2015, Nanogels from metal-chelating crosslinkers as versatile platforms applied to copper-64 pet imaging of tumors and metastases, Theranostics, 5, 277, 10.7150/thno.10904 · DOI
  98. Ma, 2012, Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid, Int. J. Pharm., 436, 25, 10.1016/j.ijpharm.2012.06.007 · DOI
  99. Ma, 2017, Molecular imaging of cancer with nanoparticle-based theranostic probes, Contrast Media Mol. Imag., 1026270
  100. Maeng, 2010, Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer, Biomaterials, 31, 4995, 10.1016/j.biomaterials.2010.02.068 · DOI
  101. McCready, 2017, Radioiodine - the success story of Nuclear Medicine : 75th anniversary of the first use of Iodine-131 in humans, Eur. J. Nucl. Med. Mol. Imag., 44, 179, 10.1007/s00259-016-3548-5 · DOI
  102. Meacham, 2013, Tumour Heterogeneity and Cancer Cell Plasticity, Nature, 501, 328, 10.1038/nature12624 · DOI
  103. Miki, 2011, High-contrast fluorescence imaging of tumors in vivo using nanoparticles of amphiphilic brush-like copolymers produced by ROMP, Angew. Chem. Int. Ed., 50, 6567, 10.1002/anie.201101005 · DOI
  104. Mikolajczak, 2019, Radiometals for imaging and theranostics, current production, and future perspectives, J. Label. Compd. Radiopharmceut., 62, 615, 10.1002/jlcr.3770 · DOI
  105. Mitra, 2006, Nanocarriers for nuclear imaging and radiotherapy of cancer, Curr. Pharm. Des., 12, 4729, 10.2174/138161206779026317 · DOI
  106. Mohan, 2010, Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking, Mol. Pharm., 7, 1959, 10.1021/mp100269f · DOI
  107. Na, 2011, Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models, Biomaterials, 32, 5252, 10.1016/j.biomaterials.2011.03.076 · DOI
  108. Notni, 2018, Re-thinking the role of radiometal isotopes: towards a future concept for theranostic radiopharmaceuticals, J. Label. Compd. Radiopharmceut., 61, 141, 10.1002/jlcr.3582 · DOI
  109. Ntziachristos, 2003, Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging, Eur. Radiol., 13, 195, 10.1007/s00330-002-1524-x · DOI
  110. Oh, 2012, False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer, Am. J. Nucl. Med. Mol. Imag., 2, 362
  111. Opoku-Damoah, 2018, Functional diagnostic and therapeutic nanoconstructs for efficient probing of circulating tumor cells, ACS Appl. Mater. Interfaces, 17, 14231, 10.1021/acsami.7b17896 · DOI
  112. Pant, 2017, Radiolabelled polymeric materials for imaging and treatment of cancer: Quo Vadis?, Adv. Healthcare Mater., 1601115, 10.1002/adhm.201601115 · DOI
  113. Pappalardo, 2005, Modeling and simulation of cancer immunoprevention vaccine, Bioinformatics, 21, 2891, 10.1093/bioinformatics/bti426 · DOI
  114. Park, 2007, Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles, J. Control. Rel., 122, 305, 10.1016/j.jconrel.2007.04.009 · DOI
  115. Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2, 751, 10.1038/nnano.2007.387 · DOI · Paper page
  116. Peltek, 2019, Current outlook on radionuclide delivery systems: from design consideration to translation into clinics, J. Nanobiotechnol., 17, 90, 10.1186/s12951-019-0524-9 · DOI
  117. Peng, 2015, Polymeric multifunctional nanomaterials for theranostics, J. Mater. Chem. B, 3, 6856, 10.1039/C5TB00617A · DOI
  118. Peng, 2015, Soft fluorescent nanomaterials for biological and biomedical imaging, Chem. Soc. Rev., 44, 4699, 10.1039/C4CS00294F · DOI
  119. Pitsillides, 2003, Selective cell targeting with light-absorbing microparticles and nanoparticles, Biophys. J., 84, 4023, 10.1016/S0006-3495(03)75128-5 · DOI
  120. Pratt, 2016, Nanoparticles and radiotracers: advances toward radio-nanomedicine, Wiley Interdisciplinary Rev.-Nanomed. Nanobiotechnol., 8, 872, 10.1002/wnan.1402 · DOI
  121. Qian, 2017, Conjugated polymer nanomaterials for theranostics, Acta Pharmacol. Sin., 38, 764, 10.1038/aps.2017.42 · DOI
  122. Ramage, 2018, Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors, Semin. Oncol., 45, 236, 10.1053/j.seminoncol.2018.08.004 · DOI
  123. Rapoport, 2009, Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles, J. Control. Rel., 138, 268, 10.1016/j.jconrel.2009.05.026 · DOI
  124. Rapoport, 2010, Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging, Mol. Pharm., 7, 22, 10.1021/mp900128x · DOI
  125. Repenko, 2017, Bio-degradable highly fluorescent conjugated polymer nanoparticles for bio-medical imaging applications, Nat. Commun., 8, 10.1038/s41467-017-00545-0 · DOI
  126. Rhee, 2014, Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy, Mar. Drugs, 12, 6038, 10.3390/md12126038 · DOI
  127. Rogosnitzky, 2016, Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms, Biometals, 29, 365, 10.1007/s10534-016-9931-7 · DOI
  128. Rossin, 2005, 64Cu-labeled folate-conjugated shell cross- linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation, J. Nucl. Med., 46, 1210
  129. Saxena, 2006, Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice, Int. J. Pharm., 308, 200, 10.1016/j.ijpharm.2005.11.003 · DOI
  130. Schubert, 2011, Nanoprecipitation and nanoformulation of polymers: from history to powerful possibilities beyond poly(lactic acid), Soft Matter, 7, 1581, 10.1039/C0SM00862A · DOI
  131. Sensenig, 2012, Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo, Nanomedicine (Lond)., 7, 1425, 10.2217/nnm.12.109 · DOI
  132. Seymour, 1987, Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats, J. Biomed. Mater. Res., 21, 1341, 10.1002/jbm.820211106 · DOI
  133. Shetty, 2019, Emerging vistas in theranostic medicine, Int. J. Pharm., 558, 29, 10.1016/j.ijpharm.2018.12.068 · DOI
  134. Shukla, 2013, Chitosan-based nanomaterials: a state-of-the-art review, Int. J. Biol. Macromol., 59, 46, 10.1016/j.ijbiomac.2013.04.043 · DOI
  135. Singh, 2009, Nanoparticle-based targeted drug delivery, Exp. Mol. Pathol., 86, 215, 10.1016/j.yexmp.2008.12.004 · DOI
  136. Singh, 2013, Radiolabeled nanogels for nuclear molecular imaging, Macromol. Rapid Commun., 34, 562, 10.1002/marc.201200744 · DOI
  137. Sneider, 2017, Remotely triggered nano-theranostics for cancer applications, Nanotheranostics, 1, 1, 10.7150/ntno.17109 · DOI
  138. Snipstad, 2017, Ultrasound Med. Biol., 43, 2651, 10.1016/j.ultrasmedbio.2017.06.029 · DOI
  139. Solnes, 2020, Theranostics: leveraging molecular imaging and therapy to impact patient management and secure the future of nuclear medicine, J. Nucl. Med., 61, 311, 10.2967/jnumed.118.220665 · DOI
  140. Stockhofe, 2014, Radiolabeling of nanoparticles and polymers for PET imaging, Pharmaceuticals, 7, 392, 10.3390/ph7040392 · DOI
  141. Stoletov, 2020, Novel therapeutic targets for cancer metastasis, Expert Rev. Anticancer Ther., 20, 97, 10.1080/14737140.2020.1718496 · DOI
  142. Sun, 2016, Theranostic application of mixed gold and superparamagnetic iron oxide nanoparticle micelles in glioblastoma multiforme, J. Biomed. Nanotechnol., 12, 347, 10.1166/jbn.2016.2173 · DOI
  143. Tharkar, 2019, Nano-enhanced drug delivery and therapeutic ultrasound for cancer treatment and beyond, Front. Bioeng. Biotechnol., 7, 1, 10.3389/fbioe.2019.00324 · DOI
  144. Tong, 2010, Polylactide nanoparticles containing stably incorporated cyanine dyes for in vitro and in vivo imaging applications, Microsc. Res. Tech., 73, 901, 10.1002/jemt.20824 · DOI
  145. Torchilin, 2004, Targeted polymeric micelles for delivery of poorly soluble drugs, Cell. Mol. Life Sci., 61, 2549, 10.1007/s00018-004-4153-5 · DOI
  146. Ulbrich, 2016, Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies, Chem. Rev., 116, 5338, 10.1021/acs.chemrev.5b00589 · DOI
  147. Vollrath, 2013, Fluorescence imaging of cancer tissue based on metal-free polymeric nanoparticles – a review, J. Mater. Chem. B, 1, 1994, 10.1039/c3tb20089b · DOI
  148. Wadajkar, 2013, Design and application of magnetic-based theranostic nanoparticle systems, Recent Patents Biomed. Eng., 6, 47, 10.2174/1874764711306010007 · DOI
  149. Wan, 2017, A novel strategy towards AIE-active fluorescent polymeric nanoparticles from polysaccharides: preparation and cell imaging, ACS Sust. Chem. Eng., 5, 9955, 10.1021/acssuschemeng.7b01908 · DOI
  150. Wang, 2015, Polymer nanostructures synthesized by controlled living polymerization for tumor-targeted drug delivery, J. Control Rel., 219, 345, 10.1016/j.jconrel.2015.08.054 · DOI
  151. Wang, 2011, More effective nanomedicines through particle design, Small, 7, 1919, 10.1002/smll.201100442 · DOI
  152. Wang, 2018, Design and synthesis of tumor-targeting theranostic drug conjugates for SPECT and PET imaging studies, Bioorg. Chem., 76, 458, 10.1016/j.bioorg.2017.12.018 · DOI
  153. Wang, 2019, Conjugated polymer nanoparticles for imaging, cell activity regulation, and therapy, Adv. Funct. Mater., 29
  154. Wang, 2014, Polymeric materials for theranostic applications, Pharm. Res., 31, 1358, 10.1007/s11095-013-1103-7 · DOI
  155. Webb, 2014, Emerging advances in nanomedicine with engineered gold nanostructures, Nanoscale, 6, 2502, 10.1039/c3nr05112a · DOI
  156. Wu, 2015, Polymer/gold hybrid nanoparticles: from synthesis to cancer theranostic applications, RSC Adv., 5, 13787, 10.1039/C4RA16454G · DOI
  157. Xie, 2010, Nanoparticle-based theranostic agents, Adv. Drug Deliv. Rev., 62, 1064, 10.1016/j.addr.2010.07.009 · DOI
  158. Xu, 2016, Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects, Nanoscale, 8, 14222, 10.1039/C6NR02448C · DOI
  159. Xu, 2014, Bio and nanomaterials based on Fe3O4, Molecules, 19, 21506, 10.3390/molecules191221506 · DOI
  160. Yallapu, 2011, Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy, Biomaterials, 32, 1890, 10.1016/j.biomaterials.2010.11.028 · DOI
  161. Yang, 2014, Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultasound traced and triggered drug delivery system, Biomaterials, 35, 2079, 10.1016/j.biomaterials.2013.11.057 · DOI
  162. Yang, 2011, cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging, Biomaterials, 32, 4151, 10.1016/j.biomaterials.2011.02.006 · DOI
  163. Ye, 2006, Noninvasive visualization of in vivo drug delivery of poly(L-glutamic acid) using contrast-enhanced MRI, Mol. Pharmaceut., 3, 507, 10.1021/mp060052g · DOI
  164. Ye, 2006, Noninvasive visualization of in vivo drug delivery of poly(L-glutamic acid) using contrast-enhanced MRI, Mol Pharm., 3, 507, 10.1021/mp060052g · DOI
  165. Yong, 2012, Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapy, Theranostics, 2, 681, 10.7150/thno.3692 · DOI
  166. Zardad, 2016, A Review of thermo- and ultrasound-responsive polymeric systems for delivery of chemotherapeutic agents, Polymers, 8, 359, 10.3390/polym8100359 · DOI
  167. Zhang, 2017, Beam and tissue factors affecting Cherenkov image intensity for quantitative entrance and exit dosimetry on human tissue, J. Biophotonics, 10, 645, 10.1002/jbio.201500344 · DOI
  168. Zhang, 2014, Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation, Biomaterials, 35, 5148, 10.1016/j.biomaterials.2014.02.036 · DOI
  169. Zhang, 2002, Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release, J. Biomed. Mater. Res., 62, 378, 10.1002/jbm.10312 · DOI
  170. Zhao, 2016, Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy, Cancer Nanotechnol., 7, 1, 10.1186/s12645-016-0022-9 · DOI
  171. Zheng, 2012, Indocyanine green-loaded biodegradable tumor targeting nanoprobes for in vitro and in vivo imaging, Biomaterials, 33, 5603, 10.1016/j.biomaterials.2012.04.044 · DOI
  172. Zhu, 2017, Regulating near-infrared photodynamic properties of semiconducting polymer nanotheranostics for optimized cancer therapy, ACS Nano, 11, 8998, 10.1021/acsnano.7b03507 · DOI

Cited by

Sorted by citations

See all 168

Metadata

Authors
Indoria, S., Singh, V., & Hsieh, M.-F.
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2020-05
Volume
582
Pages
119314
ISSN
0378-5173
DOI
10.1016/j.ijpharm.2020.119314
Cited by
168
References
10
Language
en
Licence
Funders
Ministry of Science and Technology, Taiwan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review. https://app.cochat.ai/papers/10.1016/j.ijpharm.2020.119314
The paper
Indoria, S., Singh, V., & Hsieh, M.-F. (2020). Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2020.119314